Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS

NCT06047886 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT06047886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 1
Overall status
Recruiting
Start date
April 22, 2025
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

all, aml, cml, lymphoid malignancies, myelodysplastic syndromes, primary myelofibrosis